Biosimilar Drugs Offer Promise For Drug Price Savings, But Risks Remain

The issue of prescription drug prices continues to top the list of public concerns about health costs, and Congress and the administration are floating possible policy solutions. Solutions to this complex problem will be most effective if they are targeted and geared toward encouraging rather than undermining competition and innovation in the vibrant 21st century […]

Read More

CBO Is Wrong And Its Numbers Shouldn’t Deter Needed Reform

The Congressional Budget Office (CBO) launched its latest mistaken Obamacare-related estimate this week, predicting that a House-passed bill to repeal and replace the embattled law would lead to 23 million more uninsured people by 2026. Although CBO itself acknowledges that this latest prediction is “especially uncertain,” one thing is especially certain: CBO is wrong. We […]

Read More